Patents by Inventor Michael P. Houlne

Michael P. Houlne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8452365
    Abstract: A non-invasive method of determining the concentration of an analyte uses Raman spectral information. A high-intensity, narrow band of light (10) is applied to one side (12a) of skin tissue (12). The high-intensity light (10) enters the skin tissue and generates a Raman signal (16). A reflective material (22) is placed in a location nearest the other side (12b) of skin tissue (12). The reflective material (22) is located generally opposite of the entry (A) of the applied high-intensity light (10). The high-intensity light (10) and the Raman signal (20) that pass through the skin tissue (12) are reflected back into the skin tissue (12) via the reflective material (22). The Raman signal (16,20) is collected and the analyte concentration is determined using the collected Raman signal (16,20).
    Type: Grant
    Filed: May 24, 2006
    Date of Patent: May 28, 2013
    Assignee: Bayer HealthCare LLC
    Inventors: Mihailo V. Rebec, Michael P. Houlne
  • Patent number: 8452357
    Abstract: A non-invasive method of determining the concentration of an analyte uses Raman or fluorescence spectral information. A high-intensity band of light is applied to one side of skin tissue. The high-intensity light enters the skin tissue and generates a Raman or fluorescence signal. A Raman-generating material or fluorescence-generating material is placed in a location nearest the other side of skin tissue. The Raman-generating or fluorescence-generating material is located generally opposite of the entry of the applied high-intensity light. The Raman or fluorescence signal is collected and the analyte concentration is determined using the collected Raman signal.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: May 28, 2013
    Assignee: Bayer HealthCare LLC
    Inventors: Mihailo V. Rebec, Michael P. Houlne
  • Patent number: 7944556
    Abstract: A spectral image is corrected for optical aberrations. Tissue is exposed to a high-intensity, narrow band of light. The narrow band of light is scattered by at least one analyte in the tissue. Raman signals are optically collected from the scattered light. The Raman signals are directed to a wavelength-separating device. The Raman signals are detected as a function of intensity and wavelength to create the spectral image. The spectral image is corrected for optical aberrations using a software algorithm to spatially reassign intensity. The software may be adapted to use a reference image to make dynamic corrections. Fluorescence signals may also be collected.
    Type: Grant
    Filed: March 11, 2010
    Date of Patent: May 17, 2011
    Assignee: Bayer HealthCare LLC
    Inventors: James E. Smous, Mihailo V. Rebec, Michael P. Houlne
  • Publication number: 20100226549
    Abstract: A spectral image is corrected for optical aberrations. Tissue is exposed to a high-intensity, narrow band of light. The narrow band of light is scattered by at least one analyte in the tissue. Raman signals are optically collected from the scattered light. The Raman signals are directed to a wavelength-separating device. The Raman signals are detected as a function of intensity and wavelength to create the spectral image. The spectral image is corrected for optical aberrations using a software algorithm to spatially reassign intensity. The software may be adapted to use a reference image to make dynamic corrections. Fluorescence signals may also be collected.
    Type: Application
    Filed: March 11, 2010
    Publication date: September 9, 2010
    Applicant: Bayer HealthCare, LLC
    Inventors: JAMES E. SMOUS, Mihailo V. Rebec, Michael P. Houlne
  • Patent number: 7705980
    Abstract: A spectral image is corrected for optical aberrations. Tissue is exposed to a high-intensity, narrow band of light. The narrow band of light is scattered by at least one analyte in the tissue. Raman signals are optically collected from the scattered light. The Raman signals are directed to a wavelength-separating device. The Raman signals are detected as a function of intensity and wavelength to create the spectral image. The spectral image is corrected for optical aberrations using a software algorithm to spatially reassign intensity. The software may be adapted to use a reference image to make dynamic corrections. Fluorescence signals may also be collected.
    Type: Grant
    Filed: August 21, 2007
    Date of Patent: April 27, 2010
    Assignee: Bayer Healthcare LLC
    Inventors: James E. Smous, Mihailo V. Rebec, Michael P. Houlne
  • Publication number: 20100022860
    Abstract: A non-invasive method of determining the concentration of an analyte uses Raman or fluorescence spectral information. A high-intensity band of light is applied to one side of skin tissue. The high-intensity light enters the skin tissue and generates a Raman or fluorescence signal. A Raman-generating material or fluorescence-generating material is placed in a location nearest the other side of skin tissue. The Raman-generating or fluorescence-generating material is located generally opposite of the entry of the applied high-intensity light. The Raman or fluorescence signal is collected and the analyte concentration is determined using the collected Raman signal.
    Type: Application
    Filed: October 8, 2009
    Publication date: January 28, 2010
    Applicant: BAYER HEALTHCARE LLC
    Inventors: Mihailo V. Rebec, Michael P. Houlne
  • Patent number: 7603151
    Abstract: A non-invasive method of determining the concentration of an analyte uses Raman or fluorescence spectral information. A high-intensity band of light is applied to one side of skin tissue. The high-intensity light enters the skin tissue and generates a Raman or fluorescence signal. A Raman-generating material or fluorescence-generating material is placed in a location nearest the other side of skin tissue. The Raman-generating or fluorescence-generating material is located generally opposite of the entry of the applied high-intensity light. The Raman or fluorescence signal is collected and the analyte concentration is determined using the collected Raman signal.
    Type: Grant
    Filed: August 21, 2007
    Date of Patent: October 13, 2009
    Assignee: Bayer Healthcare LLC
    Inventors: Mihailo V. Rebec, Michael P. Houlne
  • Publication number: 20090177052
    Abstract: A non-invasive method of determining the concentration of an analyte uses Raman spectral information. A high-intensity, narrow band of light (10) is applied to one side (12a) of skin tissue (12). The high-intensity light (10) enters the skin tissue and generates a Raman signal (16). A reflective material (22) is placed in a location nearest the other side (12b) of skin tissue (12). The reflective material (22) is located generally opposite of the entry (A) of the applied high-intensity light (10). The high-intensity light (10) and the Raman signal (20) that pass through the skin tissue (12) are reflected back into the skin tissue (12) via the reflective material (22). The Raman signal (16,20) is collected and the analyte concentration is determined using the collected Raman signal (16,20).
    Type: Application
    Filed: May 24, 2006
    Publication date: July 9, 2009
    Inventors: Mihailo V. Rebec, Michael P. Houlne